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Candida orthopsilosis and Candida metapsilosis are recently described species phenotypically
indistinguishable from Candida parapsilosis. We evaluated phenotyping and molecular methods
for the detection of these species among 79 unique blood culture isolates of the C. parapsilosis
group obtained during the years 2004–2008. The isolates were screened by PCR amplification of
the secondary alcohol dehydrogenase-encoding gene (SADH) followed by digestion with the
restriction enzyme BanI, using C. parapsilosis ATCC 22019, C. orthopsilosis ATCC 96139
and C. metapsilosis ATCC 96144 as controls. Isolates with RFLP patterns distinct from C.
parapsilosis were characterized by sequence analysis of the ITS1–ITS2, 26S rRNA (D1/D2) and
SADH regions. Restriction patterns for the 3 species with each of 610 restriction enzymes were
predicted in silico using 12 available sequences. By PCR-RFLP of the SADH gene alone, four
isolates (5.1%) had a pattern identical to the C. orthopsilosis reference strain. Sequence analysis
of SADH and ITS (internal transcribed spacer) regions identified two of these isolates as C.
metapsilosis. These results were confirmed by creating a phylogenetic tree based on
concatenated sequences of SADH, ITS and 26S rRNA gene sequence regions. Optimal
differentiation between C. parapsilosis, C. metapsilosis and C. orthopsilosis was predicted using
digestion with NlaIII, producing discriminatory band sizes of: 131 and 505 bp; 74, 288 and 348
bp; and 131, 217 and 288 bp, respectively. This was confirmed using the reference strains and
79 clinical isolates. In conclusion, reliable discrimination was obtained by PCR-RFLP profile
analysis of the SADH gene after digestion with NlaIII but not with BanI. C. metapsilosis and C.
orthopsilosis are involved in a small but significant number of invasive infections in Denmark.
Abbreviations: AFLP, amplification fragment length polymorphism; AFST–EUCAST, Antifungal Susceptibility Testing Subcommittee–European Committee
on Antimicrobial Susceptibility Testing; ATCC, American Type Culture Collection; ITS, internal transcribed spacer; RAPD, randomly amplified polymorphic DNA.
The GenBank/EMBL/DDBJ accession numbers for the SADH sequences reported in this study are FJ746046–FJ746069.
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INTRODUCTION
Candida parapsilosis is one of the five most common yeasts
involved in invasive candidiasis and is particularly
common in neonates, in catheter-associated candidaemia
and in association with intravenous hyperalimentation
(Krcmery & Barnes, 2002). In Denmark, it is involved in
4% of the fungaemia cases (Arendrup et al., 2008). C.
parapsilosis is normally susceptible to most antifungal
compounds but elevated MICs for the echinocandin agents
are consistently reported for this species due to an intrinsic
mutation in the FKS hot spot (Garcia-Effron et al., 2008).
Susceptibility differences within the C. parapsilosis group
could affect therapeutic choices (van Asbeck et al., 2008).
C. parapsilosis is a complex of three genetic groups (I, II and
III) according to the results from genotypic methods,
including randomly amplified polymorphic DNA (RAPD)
analysis (Lehmann et al., 1992), karyotyping (Lott et al.,
1993), multilocus enzyme electrophoresis, ribosomal
internal transcribed spacer (ITS) sequencing (Lin et al.,
1995), DNA reassociation analysis (Roy & Meyer, 1998),
DNA topoisomerase II gene sequencing (Kato et al., 2001),
complex DNA probe pattern analysis by Southern blotting
(Enger et al., 2001) and mitochondrial DNA sequence
differences (Nosek et al., 2002). In 2005 Tavanti et al. (2005)
reported a multilocus sequence typing scheme and suggested
C. parapsilosis groups II and III should be reclassified as the
species Candida orthopsilosis and Candida metapsilosis,
respectively. C. parapsilosis was retained for group I. PCR
amplification of the secondary alcohol dehydrogenase-
encoding gene (SADH) followed by digestion of the PCR
product with the restriction enzyme BanI was proposed for
differentiation of these three new species. Subsequently,
some retrospective epidemiological studies have been
undertaken to screen for C. orthopsilosis and C. metapsilosis
among previously identified C. parapsilosis isolates showing
that a small proportion of such blood culture isolates are
actually C. orthopsilosis or C. metapsilosis, with a significant
geographical variation (Asadzadeh et al., 2009; Gomez-
Lopez et al., 2008; Gonc¸alves et al., 2010; Kocsube´ et al.,
2007; Lockhart et al., 2008; Pryce et al., 2006; Silva et al.,
2009; Tavanti et al., 2005, 2007; Tay et al., 2009).
In the present study, Candida isolates identified as C.
parapsilosis group by conventional phenotyping methods
during an ongoing population-based surveillance of candidae-
mia (Arendrup et al., 2008) were genotypically screened for C.
orthopsilosis and C. metapsilosis. Sequence analysis of selected
gene targets suggested that PCR-restriction fragment length
polymorphism (RFLP) of the SADH gene by BanI is not
sufficient for differentiating the three closely related species in
the C. parapsilosis group, and therefore, an alternative RFLP
profile algorithm is proposed for reliable identification.
METHODS
Isolates. A total of 79 clinical C. parapsilosis group isolates and 3
reference strains, C. parapsilosis ATCC 22019, C. orthopsilosis ATCC
96139 and C. metapsilosis ATCC 96144, were used in this study.
Clinical strains were obtained from Danish patients with candidaemia
during 2004–2008 (Arendrup et al., 2008). Species identification was
based on colony colour and morphology on CHROMagar, micro-
scopic morphology on cornmeal agar and use of a commercial system
(ATB ID32C). The isolates had been stored in glycerol/water at
280 uC. All strains were subcultured on CHROMagar and incubated
at 37 uC for 48 h for reconfirmation of the identification as C.
parapsilosis sensu lato. Susceptibility testing was performed according
to the European Committee on Antimicrobial Susceptibility Testing
Edef 7.1 guidelines (AFST-EUCAST, 2008).
PCR. Reference and clinical strains were subjected to amplification of
the SADH gene. A small part (about 0.5–1 ml) of a single fresh colony
was added directly, and without prior DNA extraction (Mirhendi
et al., 2007) to the PCR premix, which contained 0.5 mMof the forward
(59-GTT GAT GCT GTT GGA TTG T-39) and reverse (59-CAA TGC
CAA ATC TCC CAA-39) primers (Tavanti et al., 2005), 400 mM
deoxynucleoside triphosphate mix, 2.5 ml magnesium-free buffer,
1.5 mM MgCl2 and 1.25 U Taq DNA polymerase (Sigma-Aldrich) in
a final volume of 25 ml. A negative control (water) was included in all
PCR experiments. Conditions for PCR amplification were: 94 uC for
7 min; 35 cycles of denaturation at 95 uC for 30 s, annealing at 55 uC
for 60 s and elongation at 72 uC for 90 s; and a final extension step at
72 uC for 5 min.
RFLP. The SADH PCR products were digested for 120 min with the
restriction enzyme BanI or NlaIII (Fermentas), in a 15 ml reaction
volume containing 0.5 ml (5 U) enzyme, 1.5 ml 106buffer (supplied
with the enzyme), 5 ml PCR product and 8 ml molecular grade water.
Electrophoresis. A total of 5 ml amplified DNA and 8 ml digested
DNA product were separated by electrophoresis on 1.5 and 2%
agarose gels, respectively. The electrophoresis buffer was TBE (90 mM
Tris, 90 mM boric acid, 2 mM EDTA, pH 8.3). A 100 bp DNA ladder
was used as a molecular size marker. DNA bands were visualized by
UV transillumination and photographed.
Sequencing. The following forward and reverse primer pairs were
used for amplification and sequencing of the target DNA regions: 59-
TCC GTA GGT GAA CCT GCG G-39 and 5-TCC TCC GCT TAT
TGA TAT GC-39 for the ITS1 –5.8S rRNA gene–ITS2 region (White
et al., 1990); 59-GCA TAT CAA TAA GCG GAG GAA AAG-3 and 59-
GGT CCG TGT TTC AAG ACG-39 for the D1/D2 domain of the large
subunit of rDNA gene (26S rDNA) (Fell, 1993); and 59-GTT GAT
GCT GTT GGA TTG T-39 and 59-CAA TGC CAA ATC TCC CAA-39
for the SADH gene (Tavanti et al., 2005). Sequencing was performed
in all cases by the company MWG using a BigDye terminator cycle
sequencing kit and an ABI-3730 genetic analyzer.
Sequence analysis. Forward and reverse sequences were aligned
and compared to ensure agreement, and then subjected to nucleotide
BLAST search (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and DNASIS mul-
tiple alignment. Four separate phylogenetic analyses of sequence data
were conducted: three using each individual SADH, ITS1–ITS2 and
26S rRNA gene sequence data for sequences determined in the present
study and employing the same Candida dubliniensis data for the
outgroup; and one using concatenated SADH+ITS1–ITS2+26S rRNA
data representing the total nucleotide variation in all three regions of
the tested strains, with C. dubliniensis as the outgroup. The analyses
were run using the Bayesian inference method with the program Mr-
Bayes v.3.1.2. The evolutionary distance was calculated by employing
the general time reversible evolutionary model (nset56), which utilizes
a gamma-shaped variation in mutation rates between codons
(rates5gamma). Posterior probabilities were calculated via 2 000 000
generations (ngen52 000 000, burnin520 000) using the Monte Carlo
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Markov chain method and four simultaneous tree building chains
(nchains54), with every 100th tree saved (samplefreq5100).
Designing a new RFLP profile. The SADH sequences obtained in
this study (GenBank accession nos FJ746046–FJ746069) and all
available SADH sequences deposited in GenBank for isolates
belonging to the C. parapsilosis group (http://www.ncbi.nlm.nih.
gov/) were compared and analysed by DNASIS software. The cutting
sites of enzymes listed in the DNASIS software were predicted and
evaluated for potential to discriminate between C. parapsilosis, C.
metapsilosis and C. orthopsilosis.
RESULTS AND DISCUSSION
The colony colour of the 79 C. parapsilosis sensu lato isolates
was white-cream to pale pink on CHROMagar Candida with
slight, but not species-specific, differences among the isolates.
ITS and the 26S rRNA gene sequence are well-known targets
for most of the taxonomic studies in nearly all micro-
organisms. They are the basis of routine and research
identification of fungal pathogens and for recognizing new
species (Iwen et al., 2002). The SADH gene has been the basis
of sequencing analysis or BanI-RFLP for identification of the
C. parapsilosis group since the new species were described in
2005 by Tavanti and colleagues (Tavanti et al., 2005). Thus
these genes were chosen for comparative studies of the
isolates. The SADH gene was successfully amplified in all the
clinical isolates, as well as the reference strains, and a single
sharp band with a size of approximately 720 bp was seen for all
samples. Digestion of PCR products by the restriction enzyme
BanI resulted in three different band patterns (Fig. 1). A
double band pattern (approx. 520 and 200 bp in size) was
observed for 75/79 clinical isolates. A single band representing
the absence of a cutting site for BanI was seen for C.
orthopsilosis ATCC 96139 (Fig. 1, lane 2) and four clinical
isolates (Fig. 1, lanes 4, 5, 10 and 21). These results were
reproduced three times for these strains in order to exclude
any errors in the enzymic reaction. Finally, as expected, a three
band pattern (approx. 390, 190 and 100 bp) was observed for
C. metapsilosis ATCC 96144 (Fig. 1, lane 1) (a fourth 40 bp
band is not visible by gel electrophoresis). Thus, according to
the digestion patterns described previously (Tavanti et al.,
2005), 75 blood culture isolates were identified as C.
parapsilosis, 4 as C. orthopsilosis (strains W36279, T27682,
T19754 and F10552), and none as C. metapsilosis (Table 1).
For confirmation of the species identification obtained by
SADH-RFLP, each of the three reference strains, the four
blood culture isolates identified as C. orthopsilosis by RFLP
and three randomly selected C. parapsilosis isolates, were
sequenced for the three DNA markers: SADH, the entire
ITS1–ITS2 region and 26S rRNA (D1/D2) gene sequence.
Forward and reverse sequences determined were completely
compatible. The sequences were subjected to a nucleotide
BLAST search and sequence analysis of the SADH and ITS1–
ITS2 regions, which resulted in identification of two isolates
(strains T27682 and F10552) as C. orthopsilosis (Fig. 1, lanes
5 and 21) and two isolates (strains T19754 and W36279) as
C. metapsilosis (Fig. 1, lanes 4 and 10) (Table 1). There was
no cutting site for the enzyme BanI at in silico digestion of
the sequences of these isolates. For the American Type
Culture Collection (ATCC) reference strains and three
randomly selected C. parapsilosis isolates sequence analysis
of the SADH gene and ITS region confirmed the species
identification obtained by SADH-RFLP (Table 1). Sequence
analysis of the 26S rRNA (D1/D2) region failed to
differentiate C. parapsilosis from C. metapsilosis and C.
orthopsilosis, even for the C. orthopsilosis and C. metapsilosis
ATCC reference strains (Table 1).
To evaluate the nucleotide variation, the sequences obtained
in this study were also subjected to multiple alignment and
analysis of phylogenetic trees, separately for each region and
also concatenated for all regions. A total of 592 nt for the
SADH gene, 434 nt for the ITS1–ITS2 region, 591 nt for 26S
rRNA (data not shown) and 1617 nt for the concatenated
analysis were used. As shown in Fig. 2, two of four clinical
isolates that initially were identified as C. orthopsilosis by
SADH PCR-RFLP, grouped with C. metapsilosis ATCC
96144. The SADH sequence was identical when compared to
the two Danish C. metapsilosis isolates and did not contain a
BanI cutting site. The ATCC 96144 C. metapsilosis SADH
sequences were 95% similar to the two Danish isolates, and
the reference strain contained a BanI cutting site.
With the objective of designing a better SADH-RFLP
profile for species separation and identification of the C.
parapsilosis group, all available sequences of the SADH
gene, including the sequences obtained from the present
study and sequences previously deposited in GenBank,
were analysed and restriction patterns were predicted for
Fig. 1. Agarose gel electrophoresis of SADH PCR products
digested by the restriction enzyme BanI. Lane 1, C. metapsilosis
ATCC 96144; lane 2, C. orthopsilosis ATCC 96139; lane 3, C.
parapsilosis ATCC 22019; lanes 4–30, blood culture isolates;
lane M, 100 bp molecular size marker. Note the single band
pattern in lanes 4, 5, 10 and 21, as well as for the reference strain
C. orthopsilosis (lane 2). Note also the slightly smaller band size
for samples 4 and 10 (which were eventually identified as C.
metapsilosis).
H. Mirhendi and others
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610 (almost all available) restriction enzymes. The most
applicable enzymes were MwoI, Hpy8I, MfeI, BstENII, AfaI,
AlwI and NlaIII, but only NlaIII (FatI) and BstENII were
predicted to have cutting sites for all three species.
Comparing the predicted fragment sizes of NlaIII (FatI)
and BstENII, NlaIII was superior, due to having the
greatest difference in the main fragment sizes between the
species. For NlaIII the following fragment sizes were found:
C. parapsilosis – 131 and 505 bp, C. metapsilosis – 74, 288
and 348 bp, and C. orthopsilosis – 131, 217 and 288 bp. In
comparison the following fragment sizes were found for
BstENII: C. parapsilosis – 141 and 576 bp, C. metapsilosis
– 158 and 559 bp, and C. orthopsilosis, 141, 158 and
363 bp. The SADH PCR products of all blood culture
isolates and reference strains were digested with NlaIII
(examples are shown in Fig. 3). The fragment patterns were
as expected and in agreement with the SADH gene
sequence data. No additional C. orthopsilosis or C.
metapsilosis isolates were found among clinical isolates by
this new technique. Finally, susceptibility to amphotericin
B, caspofungin, fluconazole, itraconazole and voriconazole
were compared. Given as MICs for the two C. metapsilosis
isolates, MICs for the two C. orthopsilosis isolates and
MIC50 (range) for the 75 C. parapsilosis isolates, the values
(mg ml21) were as follows: amphotericin B, 0.5 and 0.25,
0.5 and 0.5, and 0.5 (0.125–1), respectively; caspofungin,
Table 1. Molecular identification of 79 clinical C. parapsilosis sensu lato blood culture isolates and 3 reference strains using
phenotyping and a complement of molecular methods
Strain Species identification obtained by:
SADH PCR-RFLP
with BanI
SADH gene
sequencing
ITS1–ITS2
sequencing
26S rRNA (D1/D2) gene
sequencing
SADH PCR-RFLP
with NlaIII
ATCC 22019 C. parapsilosis C. parapsilosis C. parapsilosis C. parapsilosis C. parapsilosis
ATCC 96144 C. metapsilosis C. metapsilosis C. metapsilosis C. orthopsilosis/parapsilosis/
metapsilosis
C. metapsilosis
ATCC 96139 C. orthopsilosis C. orthopsilosis C. orthopsilosis C. orthopsilosis/parapsilosis/
metapsilosis
C. orthopsilosis
W36279 & T19754 C. orthopsilosis C. metapsilosis C. metapsilosis C. orthopsilosis/parapsilosis/
metapsilosis
C. metapsilosis
T27682 & F10552 C. orthopsilosis C. orthopsilosis C. orthopsilosis C. orthopsilosis/parapsilosis/
metapsilosis
C. orthopsilosis
Remaining 75 blood
isolates
C. parapsilosis Not done* Not done* Not done* C. parapsilosis
*Three of these blood isolates underwent sequencing of the SADH gene and of the 26S rRNA (D1/D2) gene region, and one blood isolate underwent
ITS1–IRS2 sequencing, confirming the isolates to be C. parapsilosis.
Fig. 2. Genetic relationships ofC. parapsilosis
sensu lato isolated from Danish patients with
candidaemia and the three reference strains,
C. parapsilosis ATCC 22019, C. orthopsilosis
ATCC 96139 and C. metapsilosis ATCC
96144. C. dubliniensis was included as the
outgroup. The relationships were inferred based
on concatenated SADH, ITS and 26S rRNA
gene sequence data. Nodal support is given as
a posterior probability value. Bar, distance.
C. parapsilosis group: identification and epidemiology
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0.5 and 1, 0.5 and 0.5, and 2 (0.5–4), respectively;
fluconazole, 2 and 0.25, 0.5 and 1, and 1 (0.5–8),
respectively; itraconazole, 0.125 and ¡0.032, ¡0.032 and
0.125, 0.064 (¡0.032–0.125), respectively; and voricona-
zole, 0.064 and ¡0.032, ¡0.032 and 0.064, and ¡0.032
(¡0.032–0.125), respectively. Thus, no significant differ-
ences were observed.
In this study we have reported the prevalence of the recently
described species C. orthopsilosis and C. metapsilosis in a well-
defined sample of blood culture isolates from Denmark and a
new low cost PCR-RFLP method for the reliable separation
of the C. parapsilosis group into the three species. Overall,
2.5% of the isolates phenotypically identified as C. para-
psilosis were C. orthopsilosis and 2.5% were C. metapsilosis.
Table 2 summarizes the frequencies of C. orthopsilosis and C.
metapsilosis in other studies of C. parapsilosis sensu lato. In the
majority of studies, including all those with more than 100
isolates, 88% or more of the isolates were confirmed to be C.
parapsilosis in agreement with the current findings. In
Portugal, Spain and Denmark similar proportions of C.
orthopsilosis and C. metapsilosis isolates were detected
Fig. 3. Agarose gel electrophoresis of SADH PCR products of C.
parapsilosis sensu lato after digestion with NlaIII. Lanes 1, 8 and 9
are C. parapsilosis ATCC 22019 and two clinical isolates of C.
parapsilosis, respectively; lanes 2, 5 and 6 are C. orthopsilosis
ATCC 96139 and the clinical isolates T27682 and F10552,
respectively; lanes 3, 4 and 7 are C. metapsilosis ATCC 96144
reference strain and clinical isolates W36279 and T19754,
respectively; lane M, 100 bp molecular size marker.
Table 2. Summary of published studies on identification methods with distribution of C. parapsilosis, C. orthopsilosis and C.
metapsilosis
Method used for
differentiation
Source of specimens No. of isolates (%) by species Country or
region
Reference
C.
parapsilosis
C.
orthopsilosis
C.
metapsilosis
MLST, RAPD-PCR,
SADH RFLP
Various clinical sources 20 (74.1%) 7 (25.9%) 0 USA, Europe,
Africa, Asia
Tavanti et al. (2005)
Direct PCR-sequencing
of BacTec
Blood and other clinical
sources
8 (88.9%) 1 (11.1%) 0 Australia Pryce et al. (2006)
ITS sequencing, RAPD
PCR, phenotyping data
Blood and other clinical
sources
18 (90%) 0 2 (10%) Hungary Kocsube´ et al. (2007)
SADH-RFLP, AFLP Various clinical sources 277 (95.5%) 13 (4.5%) NI Italy Tavanti et al. (2007)
SADH-RFLP, AFLP Various clinical sources 375 (94.9%) NI 20 (5.1%) Italy Hensgens et al. (2009)
ITS sequencing Blood 67 (85.9%) 5 (6.4%) 6 (7.7%) Spain Gomez-Lopez et al.
(2008)
SADH-RFLP Invasive clinical samples 1762 (92.1%) 117 (6.1%) 34 (1.8%) Global study
(89 countries)
Lockhart et al. (2008)
ITS-sequencing, RAPD
PCR
Blood 29 (70.7%) 10 (24.4%) 2 (4.9%) Malaysia Tay et al. (2009)
PCR with specific
primers, SADH-RFLP,
D1/D2 and ITS
sequencing
Blood (66) and other
clinical sources (48)
109 (95.6%) 5 (4.4%) 0 Kuwait Asadzadeh et al.
(2009)
SADH-RFLP Clinical and
environmental sources
160 (94.67%) 4 (2.37%) 5 (2.96%) Portugal Silva et al. (2009)
ITS sequencing Blood 126 (88.1%) 13 (9.1%) 4 (2.8%) Brazil Gonc¸alves et al.
(2010)
SADH-RFLP, SADH,
ITS and 26S
sequencing
Blood 75 (95%) 2 (2.5%) 2 (2.5%) Denmark Present study
NI, Not indicated.
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(Gomez-Lopez et al., 2008; Silva et al., 2009), while C.
orthopsilosis was more frequent than C. metapsilosis in a
worldwide study with almost 2000 isolates (Lockhart et al.,
2008) and in two smaller studies from Malaysia and Kuwait
(Tay et al., 2009; Asadzadeh et al., 2009). To what extent these
observations reflect true differences compared to method-
dependent effects remains to be elucidated. Some studies have
used SADH-RFLP with BanI, which we found unreliable for
identifying C. metapsilosis. Some studies have used PCR
sequencing of the D1/D2 region of 26S rRNA gene; however,
by sequence analysis (Table 1) including the use of
phylogenetic trees, we showed that this region is not a
suitable target for separation of the species within the C.
parapsilosis group. The 26S rRNA gene sequence is generally a
highly conserved region, particularly in yeasts (Iwen et al.,
2002). Thus it is foreseeable that 26S rRNA (D1/D2) gene
sequence may not be an optimal marker for differentiating
closely related species.
Since the description of C. orthopsilosis and C. metapsilosis in
2005 (Tavanti et al., 2005), several methods have been
proposed to identify and differentiate these species from C.
parapsilosis sensu stricto. Tavanti et al. (2005) proposed PCR
amplification of the SADH gene followed by restriction
digestion with BanI, and used amplification fragment length
polymorphism (AFLP) for identification and genotyping of
about 400 isolates previously classified as C. parapsilosis.
AFLP was shown to identify C. orthopsilosis (Tavanti et al.,
2007) and C. metapsilosis (Hensgens et al., 2009) to the
species level, and to be an efficient genotyping tool as well,
delineating intraspecific genetic relatedness. Campa et al.
(2008) developed an oligonucleotide microarray based on
the arrayed-primer extension technique to simultaneously
identify pathogenic fungi. They designed probes comple-
mentary to the ITS1 and ITS2 region for identification of 24
species, including C. parapsilosis, C. orthopsilosis and C.
metapsilosis. Based on the major DNA fragments of the
RAPD analysis profiles, Tay et al. (2009) identified the
isolates as types P1 to P5. Sequence analysis of the ITS region
of the isolates identified RAPD type P1 as C. parapsilosis, P2
and P3 as C. orthopsilosis, and P4 as C. metapsilosis. van
Asbeck et al. (2008) reported the correlation of RFLP
genotyping with ITS sequence, RAPD and multilocus
sequencing for the C. parapsilosis group. According to
Borman et al. (2009) pyrosequencing analysis of 20
nucleotides of the ITS2 region rapidly and robustly
distinguished the three species. Finally, Asadzadeh et al.
(2009) introduced primers derived from unique sequences
within the ITS1–5.8S rDNA–ITS2 region for the purpose of
differentiating the three species. All these methods have the
advantages of a sequencing-based approach, but are time
consuming and labour intensive, and some are expensive.
In our hands the SADH PCR-RFLP with the enzyme BanI
successfully separated C. parapsilosis sensu stricto from the
two new species, but the band patterns of C. orthopsilosis
and C. metapsilosis were so similar that misclassification of
C. metapsilosis as C. orthopsilosis must be expected in a
routine setting. As PCR-RFLP is an attractive method due
to low cost, we carefully analysed the SADH region in the
C. parapsilosis complex for differences that predicted
individual RFLP patterns and confirmed that the use of
SADH-PCR followed by digestion by NlaIII could be a
more reliable method for differentiating the three species.
Further studies using this method and a higher number of
C. metapsilosis and C. orthopsilosis isolates are needed to
confirm the robustness of the method.
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